Antibiotic insight may help in battle against bacterial resistance 19 July 2017 | By Dr Zara Kassam (Drug Target Review) Bacteria or 'superbugs' that have adapted to resist multiple antibiotics are responsible for around 700,000 deaths globally a year; new types of antibiotics are urgently needed...
Researchers find new genes link to arthritis in bone marrow lesions 19 July 2017 | By Niamh Marriott (Drug Target Review) Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.
Scientists discover new bacterial defence mechanism of CRISPR-Cas system 19 July 2017 | By Drug Target Review A team of researchers – headed by the University of Zurich – have discovered a new mechanism by which bacteria are protected from invading viruses and molecular parasites.
£86 million funding announced for UK medicine and technology 18 July 2017 | By Drug Target Review The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.
Feinstein Institute identifies potential cause for lupus 18 July 2017 | By Sarah Wills (Drug Target Review) A protein has been identified as a possible cause for the adverse reaction of the immune system in patients suffering from lupus.
CNIC scientists find the key to improved cancer immunotherapy 18 July 2017 | By Dr Zara Kassam (Drug Target Review) The study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumour immunity...
New device detects tumour cells in blood 18 July 2017 | By Niamh Marriott (Drug Target Review) A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and noninvasively...
Two new genes linked to Alzheimer’s risk 18 July 2017 | By Sarah Wills (Drug Target Review) Researchers have identified two genes that influence a person’s risk of developing Alzheimer’s disease.
£1.5 million grant awarded to tackle psychosis in India 17 July 2017 | By Niamh Marriott (Drug Target Review) University of Warwick researchers are to improve the lives of India's millions of psychosis sufferers.
New data network for Huntington’s disease research 17 July 2017 | By Niamh Marriott (Drug Target Review) The first data network for this research could also be the blueprint for similar data networks for research into other conditions...
Study reveals cells can be reprogrammed to repair severe liver injury 17 July 2017 | By Niamh Marriott (Drug Target Review) A new study has revealed that bile duct cells can switch to become normal liver cells to help repair the liver after severe damage.
Elsevier launches The Hive to showcase Pharma/ biotech start-ups 14 July 2017 | By Niamh Marriott (Drug Target Review) Elsevier has announced that applications and nominations for The Hive, its innovation hub for biotech and pharmaceutical startups, are now open.
DFG approves 7 new research units and a new clinical research unit 14 July 2017 | By Niamh Marriott (Drug Target Review) Topics range from planet formation and male infertility to market analysis for agricultural land and total of around €19 million for first funding period…
Heart failure is associated with loss of important gut bacteria 14 July 2017 | By Niamh Marriott (Drug Target Review) In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals.
Targeting ‘broken’ metabolism in immune cells reduces inflammatory disease 13 July 2017 | By Niamh Marriott (Drug Target Review) Scientists have uncovered a way to ‘program’ immune cells to cause less damage to the body, by tapping into a ‘broken’ chemical pathway in inflammation.
